Inflammatory Bowel Diseases: Does One Histological Score Fit All?
暂无分享,去创建一个
[1] E. Grisan,et al. Artificial Intelligence enabled histological prediction of remission or activity and clinical outcomes in ulcerative colitis. , 2023, Gastroenterology.
[2] C. Riccardi,et al. Association of GILZ with MUC2, TLR2, and TLR4 in Inflammatory Bowel Disease , 2023, International journal of molecular sciences.
[3] M. Fassan,et al. Correction to: Simplified Histologic Mucosal Healing Scheme (SHMHS) for inflammatory bowel disease: a nationwide multicenter study of performance and applicability , 2022, Techniques in Coloproctology.
[4] Jakob Nikolas Kather,et al. Artificial intelligence in histopathology: enhancing cancer research and clinical oncology , 2022, Nature Cancer.
[5] C. Riccardi,et al. The novel role of glucocorticoid-induced leucine zipper as a marker of mucosal healing in inflammatory bowel diseases. , 2022, Pharmacological research.
[6] A. Beck,et al. Artificial Intelligence Enables Quantitative Assessment of Ulcerative Colitis Histology , 2022, medRxiv.
[7] Lirsac Marion,et al. Histological Indices and Risk of Recurrence in Crohn's Disease: A Retrospective Study of a Cohort of Patients in Endoscopic Remission. , 2022, Inflammatory bowel diseases.
[8] E. Grisan,et al. PICaSSO Histologic Remission Index (PHRI) in ulcerative colitis: development of a novel simplified histological score for monitoring mucosal healing and predicting clinical outcomes and its applicability in an artificial intelligence system , 2022, Gut.
[9] L. Peyrin-Biroulet,et al. ECCO Position on harmonization of Crohn's disease mucosal histopathology. , 2022, Journal of Crohn's & colitis.
[10] C. Riccardi,et al. A recombinant glucocorticoid‐induced leucine zipper protein ameliorates symptoms of dextran sulfate sodium‐induced colitis by improving intestinal permeability , 2021, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[11] Jakob Nikolas Kather,et al. Gastrointestinal cancer classification and prognostication from histology using deep learning: Systematic review. , 2021, European journal of cancer.
[12] R. Pai,et al. Utilizing Deep Learning to Analyze Whole Slide Images of Colonic Biopsies for Associations Between Eosinophil Density and Clinicopathologic Features in Active Ulcerative Colitis. , 2021, Inflammatory bowel diseases.
[13] V. Villanacci,et al. Histopathology of IBD Colitis. A practical approach from the pathologists of the Italian Group for the study of the gastrointestinal tract (GIPAD) , 2021, Pathologica.
[14] A. Griffiths,et al. STRIDE-II: An Update on the Selecting Therapeutic Targets in Inflammatory Bowel Disease (STRIDE) Initiative of the International Organization for the Study of IBD (IOIBD): Determining Therapeutic Goals for Treat-to-Target strategies in IBD. , 2020, Gastroenterology.
[15] A. Ananthakrishnan,et al. Treat to target: The role of histologic healing in inflammatory bowel diseases: A systematic review and meta-analysis. , 2020, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.
[16] L. Peyrin-Biroulet,et al. ECCO Position Paper: Harmonisation of the approach to Ulcerative Colitis Histopathology. , 2020, Journal of Crohn's & colitis.
[17] M. Cravo,et al. Comparing the Continuous Geboes Score With the Robarts Histopathology Index: Definitions of Histological Remission and Response and their Relation to Faecal Calprotectin Levels. , 2020, Journal of Crohn's & colitis.
[18] J. Cotter,et al. Comparison of the Nancy index with continuous Geboes score: histological remission and response in ulcerative colitis. , 2020, Journal of Crohn's & colitis.
[19] D. Rubin,et al. Histologic Healing is More Strongly Associated with Clinical Outcomes in Ileal Crohn's Disease than Endoscopic Healing. , 2019, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.
[20] M. Gurcan,et al. Digital pathology and artificial intelligence. , 2019, The Lancet. Oncology.
[21] C. Riccardi,et al. How Glucocorticoids Affect the Neutrophil Life , 2018, International journal of molecular sciences.
[22] V. Villanacci,et al. Colonic hypereosinophilia in ulcerative colitis may help to predict the failure of steroid therapy , 2018, Techniques in Coloproctology.
[23] F. Rieder,et al. The emerging role of histologic disease activity assessment in ulcerative colitis. , 2018, Gastrointestinal endoscopy.
[24] C. Riccardi,et al. GILZ restrains neutrophil activation by inhibiting the MAPK pathway , 2018, Journal of leukocyte biology.
[25] I. Nagtegaal,et al. Assessment of Histological Remission in Ulcerative Colitis: Discrepancies Between Daily Practice and Expert Opinion , 2018, Journal of Crohn's & Colitis.
[26] V. Villanacci,et al. Usefulness of Different Pathological Scores to Assess Healing of the Mucosa in Inflammatory Bowel Diseases: A Real Life Study , 2017, Scientific Reports.
[27] K. Geboes,et al. Disease activity and mucosal healing in inflammatory bowel disease: a new role for histopathology? , 2017, Virchows Archiv.
[28] B. Feagan,et al. Histologic scoring indices for evaluation of disease activity in ulcerative colitis. , 2017, The Cochrane database of systematic reviews.
[29] A. Sapino,et al. Eosinophilia – associated basal plasmacytosis: an early and sensitive histologic feature of inflammatory bowel disease , 2017, Acta Pathologica, Microbiologica et Immunologica Scandinavica (APMIS).
[30] C. Rosty,et al. Histopathological findings of extra-ileal manifestations at initial diagnosis of Crohn’s disease-related ileitis , 2016, Virchows Archiv.
[31] B. Sands,et al. Mucosal Healing Is Associated With Improved Long-term Outcomes of Patients With Ulcerative Colitis: A Systematic Review and Meta-analysis. , 2016, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.
[32] S. Vermeire,et al. A Simplified Geboes Score for Ulcerative Colitis , 2016, Journal of Crohn's & colitis.
[33] G. D'Haens,et al. Histologic scoring indices for evaluation of disease activity in Crohn's disease. , 2016, The Cochrane database of systematic reviews.
[34] S. Anita,et al. Histological activity and basal plasmacytosis are nonpredictive markers for subsequent relapse in ulcerative colitis patients with mucosal healing , 2016 .
[35] L. Stitt,et al. Development and validation of a histological index for UC , 2015, Gut.
[36] S. Travis,et al. Development and validation of the Nancy histological index for UC , 2015, Gut.
[37] B. Warren,et al. Beyond endoscopic mucosal healing in UC: histological remission better predicts corticosteroid use and hospitalisation over 6 years of follow-up , 2015, Gut.
[38] C. Langner,et al. Histological remission in inflammatory bowel disease: where are we, and where are we going? , 2015, Journal of Crohn's & colitis.
[39] S. Travis,et al. Systematic review: histological remission in inflammatory bowel disease. Is 'complete' remission the new treatment paradigm? An IOIBD initiative. , 2014, Journal of Crohn's & colitis.
[40] O. Giouleme,et al. Severe eosinophilic infiltration in colonic biopsies predicts patients with ulcerative colitis not responding to medical therapy , 2014, Colorectal disease : the official journal of the Association of Coloproctology of Great Britain and Ireland.
[41] G. Reboldi,et al. Endoscopic biopsy samples of naïve "colitides" patients: role of basal plasmacytosis. , 2014, Journal of Crohn's & colitis.
[42] G. D'Haens,et al. A Systematic Review of the Measurement of Endoscopic Healing in Ulcerative Colitis Clinical Trials: Recommendations and Implications for Future Research , 2014, Inflammatory bowel diseases.
[43] M. Vandervoort,et al. Histologic Evaluation of Ulcerative Colitis: A Systematic Review of Disease Activity Indices , 2014, Inflammatory bowel diseases.
[44] G. Petris,et al. The histopathological approach to inflammatory bowel disease: a practice guide , 2014, Virchows Archiv.
[45] G. Petris,et al. European consensus on the histopathology of inflammatory bowel disease. , 2013, Journal of Crohn's & colitis.
[46] P. Rutgeerts,et al. Prognostic Value of Serologic and Histologic Markers on Clinical Relapse in Ulcerative Colitis Patients With Mucosal Healing , 2012, The American Journal of Gastroenterology.
[47] M. Neurath,et al. Mucosal healing in inflammatory bowel diseases: a systematic review , 2012, Gut.
[48] P. Rutgeerts,et al. Early mucosal healing with infliximab is associated with improved long-term clinical outcomes in ulcerative colitis. , 2011, Gastroenterology.
[49] C. O'Morain,et al. Review article: defining remission in ulcerative colitis , 2011, Alimentary pharmacology & therapeutics.
[50] G. Porro,et al. Mucosal healing predicts late outcomes after the first course of corticosteroids for newly diagnosed ulcerative colitis. , 2011, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.
[51] B F Warren,et al. European evidence-based Consensus on the diagnosis and management of ulcerative colitis: Definitions and diagnosis. , 2008, Journal of Crohn's & colitis.
[52] N. Harpaz,et al. Histologic inflammation is a risk factor for progression to colorectal neoplasia in ulcerative colitis: a cohort study. , 2007, Gastroenterology.
[53] M. Vatn,et al. Mucosal healing in inflammatory bowel disease: results from a Norwegian population-based cohort. , 2007, Gastroenterology.
[54] R. Yantiss,et al. Diagnostic difficulties in inflammatory bowel disease pathology , 2006, Histopathology.
[55] S Al-Haddad,et al. The role of eosinophils in inflammatory bowel disease , 2005, Gut.
[56] A. Öst,et al. A reproducible grading scale for histological assessment of inflammation in ulcerative colitis , 2000, Gut.
[57] M F Dixon,et al. Classification and grading of gastritis. The updated Sydney System. International Workshop on the Histopathology of Gastritis, Houston 1994. , 1996, The American journal of surgical pathology.
[58] C. Bernstein,et al. Patchiness of mucosal inflammation in treated ulcerative colitis: a prospective study. , 1995, Gastrointestinal endoscopy.
[59] R. Pounder,et al. Early mucosal changes in Crohn's disease. , 1993, Gut.
[60] S. Riley,et al. Microscopic activity in ulcerative colitis: what does it mean? , 1991, Gut.
[61] W. Tremaine,et al. Coated oral 5-aminosalicylic acid therapy for mildly to moderately active ulcerative colitis. A randomized study. , 1987, The New England journal of medicine.
[62] S. Truelove,et al. Biopsy Studies in Ulcerative Colitis , 1956, British medical journal.